Karin Dott

2.3k total citations · 2 hit papers
24 papers, 2.0k citations indexed

About

Karin Dott is a scholar working on Genetics, Virology and Epidemiology. According to data from OpenAlex, Karin Dott has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Karin Dott's work include Virus-based gene therapy research (9 papers), HIV Research and Treatment (7 papers) and Hemophilia Treatment and Research (5 papers). Karin Dott is often cited by papers focused on Virus-based gene therapy research (9 papers), HIV Research and Treatment (7 papers) and Hemophilia Treatment and Research (5 papers). Karin Dott collaborates with scholars based in France, United Kingdom and United States. Karin Dott's co-authors include Yves Rivière, Jean‐Pierre Lecocq, Marc Girard, Luc Montagnier, Andréa Pavirani, Marie Paule Kiény, Michel Lazdunski, Guy Champigny, Pascal Barbry and Wilfried Dalemans and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Karin Dott

24 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation

1991 579 citations Wilfried Dalemans, Pascal Barbry et al. Nature profile →
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

1987 437 citations Bruno Guy, Yves Rivière et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Dott France	17	773	590	548	382	380	24	2.0k
Masashi Fukasawa Japan	32	1.2k 1.5×	827 1.4×	77 0.1×	483 1.3×	693 1.8×	62	2.9k
Tamás Oravecz United States	28	735 1.0×	1.5k 2.6×	95 0.2×	301 0.8×	1.0k 2.7×	47	3.0k
John Wakefield United States	23	685 0.9×	1.2k 2.1×	332 0.6×	495 1.3×	320 0.8×	34	2.1k
Bishnu P. De United States	35	178 0.2×	1.0k 1.7×	192 0.4×	549 1.4×	354 0.9×	91	2.9k
J R Rusche United States	18	1.4k 1.8×	937 1.6×	67 0.1×	682 1.8×	1.1k 2.9×	25	2.9k
Paul H. Naylor United States	23	273 0.4×	542 0.9×	38 0.1×	131 0.3×	601 1.6×	104	1.9k
John L. Foster United States	24	787 1.0×	781 1.3×	31 0.1×	389 1.0×	552 1.5×	39	1.9k
Earl E. Henderson United States	26	424 0.5×	1.0k 1.7×	31 0.1×	299 0.8×	499 1.3×	91	2.0k
Barbara A. Torres United States	27	145 0.2×	661 1.1×	75 0.1×	108 0.3×	1.2k 3.3×	53	2.5k
Pilar Lucas Spain	18	497 0.6×	643 1.1×	51 0.1×	193 0.5×	635 1.7×	39	1.6k

Countries citing papers authored by Karin Dott

Since Specialization

Citations

This map shows the geographic impact of Karin Dott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Dott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Dott more than expected).

Fields of papers citing papers by Karin Dott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Dott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Dott. The network helps show where Karin Dott may publish in the future.

Co-authorship network of co-authors of Karin Dott

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Dott. A scholar is included among the top collaborators of Karin Dott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Dott. Karin Dott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rose, Ken A., Adrian K. Allan, Genevieve Stapleton, et al.. (2001). Neurosteroid Hydroxylase CYP7B. Journal of Biological Chemistry. 276(26). 23937–23944. 72 indexed citations

Spehner, Danièle, et al.. (2000). Enveloped Virus Is the Major Virus Form Produced during Productive Infection with the Modified Vaccinia Virus Ankara Strain. Virology. 273(1). 9–15. 16 indexed citations

Rose, Ken A., Genevieve Stapleton, Karin Dott, et al.. (1997). Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxy dehydroepiandrosterone and 7α-hydroxy pregnenolone. Proceedings of the National Academy of Sciences. 94(10). 4925–4930. 184 indexed citations

Champigny, Guy, Jean‐Luc Imler, Édith Puchelle, et al.. (1995). A change in gating mode leading to increased intrinsic Cl- channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild form of the disease.. The EMBO Journal. 14(11). 2417–2423. 33 indexed citations

Acres, Bruce, et al.. (1994). Directed cytokine expression in tumour cells in vivo using recombinant vaccinia virus.. PubMed. 1(1). 17–23. 10 indexed citations

Taupin, Jean‐Luc, Bruce Acres, Karin Dott, et al.. (1993). Immunogenicity of HILDA/LIF either in a Soluble or in a Membrane Anchored Form expressed In Vivo by Recombinant Vaccinia Viruses. Scandinavian Journal of Immunology. 38(3). 293–301. 17 indexed citations

Dalemans, Wilfried, Pascal Barbry, Guy Champigny, et al.. (1991). Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation. Nature. 354(6354). 526–528. 579 indexed citations breakdown →

Hareuveni, Mara, Daniel H. Wreschner, Marie Paule Kiény, et al.. (1991). Vaccinia recombinants expressing secreted and transmembrane forms of breast cancer-associated epithelial tumour antigen (ETA). Vaccine. 9(9). 618–626. 16 indexed citations

Guy, B., Michel Geist, Karin Dott, et al.. (1991). A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. Journal of Virology. 65(3). 1325–1331. 70 indexed citations

10.

Guy, B., Yves Rivière, Karin Dott, Armelle Régnault, & Marie Paule Kiény. (1990). Mutational analysis of the HIV nef protein. Virology. 176(2). 413–425. 97 indexed citations

11.

Skern, Tim, Rainer Bischoff, Sophie Jallat, et al.. (1990). Sulphation of hirudin in BHK cells. FEBS Letters. 275(1-2). 36–38. 6 indexed citations

12.

Meulien, Pierre, et al.. (1990). Increased biological activity of a recombinant factor IX variant carrying alanine at position +1. Protein Engineering Design and Selection. 3(7). 629–633. 6 indexed citations

13.

Rautmann, G, Marie Paule Kiény, Karin Dott, et al.. (1989). HIV-1 Core Proteins Expressed from Recombinant Vaccinia Viruses. AIDS Research and Human Retroviruses. 5(2). 147–157. 23 indexed citations

14.

Meulien, Pierre, T. Faure, Karin Dott, et al.. (1988). A new recombinant procoagulant protein derived from the cDNA encoding human factor VIII. Protein Engineering Design and Selection. 2(4). 301–306. 43 indexed citations

15.

Kiény, Marie Paule, et al.. (1988). Improved antlgenldty of the HIV env protein by deavage site removal. Protein Engineering Design and Selection. 2(4). 317–317. 39 indexed citations

16.

Pavirani, Andréa, Pierre Meulien, Karin Dott, et al.. (1987). Choosing a Host Cell for Active Recombinant Factor VIII Production Using Vaccinia Virus. Nature Biotechnology. 5(4). 389–392. 16 indexed citations

17.

Guy, Bruno, Yves Rivière, Christian Le Peuch, et al.. (1987). HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature. 330(6145). 266–269. 437 indexed citations breakdown →

18.

Pavirani, Andréa, Pierre Meulien, Karin Dott, et al.. (1987). Two independent domains of Factor VIII co-expressed using recombinant vaccinia viruses have procoagulant activity. Biochemical and Biophysical Research Communications. 145(1). 234–240. 10 indexed citations

19.

Kieny, M. P., G Rautmann, D Schmitt, et al.. (1986). AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus. Nature Biotechnology. 4(9). 790–795. 88 indexed citations

20.

Salle, Henri de la, Werner Altenburger, R. Elkaïm, et al.. (1985). Active γ-carboxylated human factor IX expressed using recombinant DNA techniques. Nature. 316(6025). 268–270. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact